| For: | Xie ZJ, Liu Y, Jia LM, He YC. Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer. World J Gastroenterol 2008; 14(24): 3812-3818 [PMID: 18609704 DOI: 10.3748/wjg.14.3812] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3812.htm |
| Number | Citing Articles |
| 1 |
G Solinas, G Germano, A Mantovani, P Allavena. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. Journal of Leukocyte Biology 2009; 86(5) doi: 10.1189/jlb.0609385
|
| 2 |
Yizhuo Wang, Chang Wang, Huijie Xiao, Chao Niu, Haitao Wu, Haofan Jin, Cheng Yao, Hua He, Huimin Tian, Fujun Han, Dan Li, Wei Han, Jianting Xu, Jingtao Chen, Jiuwei Cui, Wei Li. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer. Cancer Medicine 2017; 6(1) doi: 10.1002/cam4.942
|
| 3 |
Bo Tang, Shiming Yang. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221 doi: 10.1007/978-3-030-34521-1_13
|
| 4 |
Teruki Nii, Kimiko Makino, Yasuhiko Tabata. A Cancer Invasion Model Combined with Cancer-Associated Fibroblasts Aggregates Incorporating Gelatin Hydrogel Microspheres Containing a p53 Inhibitor. Tissue Engineering Part C: Methods 2019; 25(12) doi: 10.1089/ten.tec.2019.0189
|
| 5 |
GUO-QIANG SU, FU-XING ZHANG, HE-HUI MAO, XIAN-WEI LIU, YONG-SHENG ZHENG, SI-YU ZHANG, JING-JUN SU. Research of shRNAmir inhibitory effects towards focal adhesion kinase expression in the treatment of gastric cancer. Oncology Letters 2015; 9(2) doi: 10.3892/ol.2014.2725
|
| 6 |
Zoi Piperigkou, Konstantina Kyriakopoulou, Christos Koutsakis, Stylianos Mastronikolis, Nikos K. Karamanos. Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer. Cancers 2021; 13(6) doi: 10.3390/cancers13061441
|
| 7 |
Gui-Bo Wang, Xin-Yu Zhou, Xiao-Qin Wang. Relationship Between Serum Heparanase and Microscopic Venous Invasion in Patients With Hepatocellular Carcinoma. American Journal of Clinical Pathology 2010; 134(2) doi: 10.1309/AJCPPJM6VHG4LPJX
|
| 8 |
Jiuwei Cui, Lingyu Li, Chang Wang, Haofan Jin, Cheng Yao, Yizhuo Wang, Dan Li, Huimin Tian, Chao Niu, Guanjun Wang, Wei Han, Jianting Xu, Jingtao Chen, Wei Li. Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma. Cytotherapy 2015; 17(7) doi: 10.1016/j.jcyt.2015.03.605
|
| 9 |
Soo-Ling Lo, Aye Aye Thike, Soo-Yong Tan, Tony Kiat-Hon Lim, Iain Bee-Huat Tan, Su-Pin Choo, Puay-Hoon Tan, Boon-Huat Bay, George Wai-Cheong Yip. Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival. Journal of Clinical Pathology 2011; 64(2) doi: 10.1136/jcp.2010.087478
|
| 10 |
Hongcheng Liu, Xiaofeng Chen, Wen Gao, Gening Jiang. The expression of heparanase and microRNA-1258 in human non-small cell lung cancer. Tumor Biology 2012; 33(5) doi: 10.1007/s13277-012-0380-9
|